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Abstract Cancers are the secondmost common cause of non-
accidental deaths in Iran, following cardiovascular deaths.
Mazandaran, near the Caspian Littoral at north of Iran have
identified as a several-high incidence area for Esophageal
Squamous Cell Carcinoma (ESCC) in the world. Several as-
sociated risk factors, such as dietary and cultural habits, infec-
tious agents, nutritional deficiencies, too much use of tobacco
and alcohol and infection to certain DNA tumor viruses
(HPVs), including environmental and genetic factors are attrib-
uted to this disease. To explore this issue, we analyzed HPV
DNA prevalence and HPV types together in relation to tumor
sites a high-incidence population. Archived tissue blocks from
46, 69 and 62 upper, middle and lower third of esophagus,
respectively from ESCC patients were evaluated for the pres-
ence of HPV DNA by PCR using the degenerate HPV L1
consensus primer pairs MY09/MY11. The positive specimens
were evaluated by Real-time PCR to determine HPV geno-
types. From the 49 HPV positive cases, of ESCC patients, 5
(23.1 %), 11 (55 %) and 9 (56.3 %) of upper, middle and lower
third of ESCC specimens, respectively were positive by at least
one high and one low-risk HPV genotypes. In general, HPV45
and HPV11 were the most common high- risk and low-risk
HPV genotypes in HPV L1 positive cases, respectively, fol-
lowed by HPV6, HPV52 and HPV39. Therefore, the high
prevalence of HPVDNA in different anatomical sites of ESCC
patients from the Mazandaran region in North of Iran provides
more evidence for a role of HPV in this cancer.
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Introduction
Cancers are among the most common causes of death
throughout the world. It is estimated that the overall incidence
of various types of cancers will increase by 45% in developed
countries by 2030. Recent reports indicate that cancers are the
second most common cause of non-accidental deaths in Iran,
following cardiovascular deaths [1–3].
Epidemiological studies have identified several-high in-
cidence area in China, Singapore, Iran, Russia, Puerto Rico,
Chile, Brazil, Switzerland, France and South Africa [4, 5],
but the causes for striking geographical variations in the
incidence of human esophageal cancer remain ambiguous.
In India, esophageal cancer is most common, but unevenly
distributed with certain regions showing a higher preva-
lence, and, recently, an increasing trend in the rate of its
incidence has been observed [6]. Several associated risk
factors, such as dietary and cultural habits, infectious agents,
nutritional deficiencies, too much use of tobacco and
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alcohol and infection to certain DNA tumor viruses (HPVs,
EBV), including environmental and genetic factors are at-
tributed to this disease [7–10].
In the USA and other western countries tobacco, too
much alcohol drinking, diets poor in fresh fruits and vege-
tables, and low socioeconomic group have been associated
with SCC [11, 12], but a potential role of HPV has been
proposed [13, 14]. In Iran and China, alcohol and tobacco
are not considered as risk factors [15–20].
To date, more than 140 HPV genotypes have been rec-
ognized and subdivided into cutaneous and mucosal HPV
types. HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58,
59, 68, 73, and 82 are classified as high-risk (HR) types;
types 6, 11, 40, 42, 44, 54, 61, 70, 72, 81, and CP6108 are
classified as low-risk (LR) types; and types 26, 53, and 66
are considered as probably oncogenic [21, 22]. Also, HPV
types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66 are
carcinogenic to humans (Group 1). HPV 6 and HPV 11
(Group 2B) and some types of HPV genus beta are possibly
carcinogenic to human (Group 2B).
Interestingly, studies from Asian countries, especially
China, have reported relatively high percentages of HPV
positive ESCC cases when compared to reports from West-
ern European countries. There are areas, particularly in Asia,
where HPV is more commonly detected in esophageal can-
cer. Recent case series have been reported from Egypt [23],
Colombia and Chile [24], Brazil [25], Germany [26], the
Republic of Korea [27], the Islamic Republic of Iran [28],
and China [14, 29]. HPV detection in these recent studies
ranged from 0 % (Republic of Korea) to 54 % (Egypt). HPV
16 was the most common type in all studies, followed by
HPV 18.
To our knowledge, there is no study comparing the
HPV infection rates in the North of Iran. In the present
study, we examined ESCC in Mazandaran province,
Northern Iran detecting genotypes of high-risk HPV
types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and
59) and low-risk HPV types (6, 11) with respect to
different parts of esophagus.
Materials and Methods
Patients
We examined 177 formalin-fixed and paraffin-embedded
ESCC specimens (46, 69 and 62 cases of upper, middle
and lower third, respectively) from Shahid Beheshti Hospi-
tal, Babol and Amol Central Laboratory in Mazandaran,
Northern Iran, from 2004 to 2011. The patient habitats in
about 15 cities of Mazandaran province, as a region in high
incidence of esophageal cancer. In every case, the patholog-
ical diagnoses were rendered by local pathologists. The
demographic and medical information including age, gen-
der, habitant, tumor site was obtained from patient medical
records.
DNA Extraction
Five to 10 slides (depends on type of the specimen: biopsy
or surgery) were deparaffinized in xylene and absolute al-
cohol, then the lysis buffer (300 mmol/l NaCl; 50 mmol/
l Tris·HCl pH 8.0; 0.2 % SDS) was added into the tube with
proteinase K (200 mg/l), and the solution was incubated at
55 °C overnight until it became clear. Then DNA was
extracted using High Pure PCR Template Preparation Kit
(Roche Diagnostics GmbH, Mannheim Germany).
Real-Time PCR for Qualitative Detection of HPV-DNA
All DNA extracted from ESCC specimens and positive or
negative controls for HPV detection and genotyping per-
formed with high-sensitive real-time PCR (Corbett Rotor-
Gene 6000 Sequence Detection System). The 12-μl reaction
mixture included and SYBR-Green PCR master mix (Max-
ima® SYBR Green qPCR Master Mix (2X), Applied Fer-
mentas, EU); forward and reverse primers at 10 pmol per
reaction for MY09 (5′-CGT CCM AAR GGA WAC TGA
TC-3′) and MY11 (5′-GCM CAG GGW CAT AAY AAT
GG-3′) from L1 genes; and 6 μl DNA sample. PCR reac-
tions were as follows: The amplification conditions were a
three-step cycle of 95 °C for 10 min (for initial denatur-
ation), 95 °C for 15 s, 55 °C for 30s and 72 °C for 30s (5
repeats). For cycling 2: 95 °C for 15 s, 55 °C for 30s and
72 °C for 30s for a total of 40 cycles.
Real-Time PCR for HR&LR-HPV
All HPV-DNA positive specimens of ESCC for HPV gen-
otyping performed with high-sensitive real-time PCR (Rotor
Gene 6000, Corbett Research, Australia & USA). The 13-μl
reaction mixture included AmpliSense HPV HCR genotype
FRT PCR Kit for High-Risk genotyping and then all HPV-
DNA positive samples were tested by AmpliSense HPV 6/
11 FRT PCR Kit for detection of Low-risk genotyping
(Federal State Institution of Science Central Research Insti-
tute of Epidemiology, 3A Novogireevskaya Street Moscow
111123 Russia).
Quality Control
DNA preparation, PCR setup, and PCR product detection
were approved in separated spaces with specimens mov-
ing through the laboratory in one direction only. The
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human β-globin gene and HPV L1 were tested in these
controls to confirm the absence of contamination during
DNA preparation.
In each PCR reaction tube the following controls were
included: β-globin as a Housekeeping gene for DNA prep-
aration control (β-globin Forward: 5′-TGG GTT TCT GAT
AGG CAC TGA CT-3′; β-globin Reverse: 5′-AAC AGC
ATC AGG AGT GGA CAG AT-3′); negative controls with-
out a DNA template; and one positive control containing
HPV-18 was extracted on Hela cell line and HPV-16 and
HPV-18 approved by WHO.
Assay results were interpreted and used for this study
only when controls met the following criteria: 1. All nega-
tive controls were negative; 2. ESCC DNA was positive;
and 3. Positive control was positive. In cases where any
negative control was positive, testing was repeated.
Statistical Analysis
A χ2 test was used to compare categorical data. A P-value
less than 0.05 were considered statistically significant. Sta-
tistical analysis was performed with SPSS 14.
Results
The mean ± SD age studied patients for the 46 upper, 69
middle and 62 lower third of esophagus was 67.6±9.7, 65.6
±11.0 and 67.4±11.9 years, respectively. 58.7 %, 56.9 %
and 50 % of upper, middle and lower specimens belong to
males. We found no difference with respect to age (χ20
4.03; df06; ρ00.67), gender (χ200.94; df02; ρ00.63) and
anatomical sites of esophagus (as shown in Table 1).
From 46 (28.3 %) upper, 69 (29 %) middle and 62
(25.8 %) lower third of ESCC cases 28.3 %, 29 % and
25.8 % were HPV L1 positive, respectively (Fig. 1) (χ20
0.175; df02; ρ00.916). Using the Real-time PCR method, a
total of 14 genotypes including HPV6, 11, 16, 18, 31, 33,
35, 39, 45, 51, 52, 56, 58 and 59 were detected. Of 49 HPV
L1 positive specimens of ESCC, 23.1 % of patient in upper,
55 % in middle and 56.3 % of them in lower third of ESCC
samples were positive by at least one of the high and low-
risk HPV genotypes. The most prevalent genotype was
HPV11 and HPV45 was detected in 20 % in middle third
of the HPV L1 positive cases. HPV6 was the second most
prevalent genotype in middle third and was found in 15 %,
followed by HPV39 in 10 % of HPV L1 positive cases of
middle third of ESCC specimens. HPV52 was the more
common prevalent genotype (18.8 %) in lower third and
the second more prevalent genotypes in this site of esopha-
gus were HPV11, 39 and 45 with 12.5 % for each type. In
addition, many other HPV genotypes were found, although
less common, in every three third of ESCC cases (Table 2
and Fig. 2). Also, among HPV L1 positive cases, 26.5 %
were infected by single genotype and 20.4 % of them were
co-infected with more than one HPV type (Table 3).
As shown in Table 1 the difference between the numbers
of HPV genotypes according to each part of esophagus are
statistically significant.
Discussion
In the present series, men and women were nearly equal
represented, a gender distribution similar to most high inci-
dence areas where tobacco and alcohol are not the main risk
factors for ESCC, such as in northeastern or in central China
[30–32]. Molecular evidence of ESCC in Mazandaran
appears different from those in high incidence areas of
HPV infection.
To our knowledge, this study is the first report on the
molecular evaluated of ESCC from patients of Mazandaran
province, a possibly high incidence area in northern Iran.
Table 1 The description of
gender, age and HPV positivity
by different parts of esophagus
in ESCC patients
Number of patients (N/%) Upper third (N/%) Middle third (N/%) Lower third (N/%)
Gender
Male 98 (55.4) 27 (58.7) 39 (56.5) 31 (50)
Female 79 (44.6) 19 (41.3) 30 (43.5) 31 (50)
Age
<55 35 (19.8) 6 (13) 17 (24.6) 12 (19.4)
55 to 64 28 (15.8) 10 (21.7) 9 (13) 9 (14.5)
65 to 74 69 (39) 20 (43.5) 25 (36.2) 24 (38.7)
>075 45 (25.4) 10 (21.7) 18 (26.1) 17 (27.4)
HPV infection
Positive 49 (27.7) 13 (28.3) 20 (29) 16 (25.8)
Negative 128 (72.3) 33 (71.2) 49 (71) 46 (74.2)
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Although limited to 177 cases, this series is of interest since
there is no report for ESCC in Iran except for a study in
Tehran, Central of Iran [28] and Turkmen Sahra in Northeast
Iran [33].
We observed a prevalence of HPV DNA of 27.7 %, far
below the high prevalence reported in high incidence areas
of China (30–82.8 %) [14, 29, 34–36], Northeast Iran
(49 %) [33], or South African (44–46 %) [37, 38]. The
earlier studies in ESCC samples of Iranian patients that
associated HPV with 23.6 % [28] and 36.8 % [39] in Central
of Iran, and 49.4 % [33] of cases of esophageal cancer in
northeast of Iran used PCR.
We employed a sensitive real-time PCR assay for analy-
sis of paraffin-embedded tissue from patients with Esopha-
geal Squamous Cell Carcinoma According to Fig. 2 many
HPV genotypes have not been previously reported in other
ESCC studies of Iran.
We also detected HPV genotypes 39, 45, 56, 58 and 59
which has never before been shown before present in ESCC
in Iran and many other countries. In contrast, the earlier
studies have shown that HPV types 16 and 18 are more
commonly detected and more frequently associated with
ESCC. Also, HPV genotype 11 and 6 are two of the pre-
dominant type in this study. In our study, we found HPV
type 16 DNA and HPV type 18 DNA were present in only
one of the lower (2 %) and middle part (2 %) of HPV
positive cases.
In general, HPV type 52 DNAwas present in 10.2 % and
each one of HPV types 31, 33, 35 and 56 DNAwas present
in 4.1 % in HPV DNA positive cases. Also, HPV types 58
and 59 DNAwas present in only one sample whereas, HPV














Fig. 1 Percentage of HPV L1 DNA in different part of esophagus in
ESCC patients
Table 2 Detection of HPV genotypes in HPV L1 positive in different
anatomical sites of patients with ESCC
HPV genotype Third of esophagus
Upper Middle Lower
HPV-6 1 3 1
HPV-11 0 5 2
HPV-16 0 0 1
HPV-18 0 1 0
HPV-31 1 1 0
HPV-33 1 1 0
HPV-35 0 1 1
HPV-39 0 2 2
HPV-45 1 4 2
HPV-51 0 0 0
HPV-52 1 1 3
HPV-56 0 1 1
HPV-58 0 0 1
HPV-59 0 1 0










































































































































































































Fig. 2 Relative frequency (%) of HPV genotypes in HPV L1 positive
patients with ESCC in Mazandaran, near the Caspian Littoral. a Upper;
b Middle and (c) Lower third of Esophagus
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earlier studies in Iran showed, HPV type 16, 18, 31 and 33
[28], only HPV type DNA 16 and 18 [39] and also HPV
type DNA 16, 18, 6, 66 and 52 [33].
In European study in Uppsala, Sweden, 16 % of patient
with ESCC have HPV DNA by real-time PCR and they
reported only HPV genotype 16 DNA between HPV types
of 16, 18, 31, 33, 35, 45, 52 and 67 [40].
In Transkei of South Africa, researchers found HPV
type 16 DNA was present in only two cases, whereas
HPV type 18 DNA was not detected. Also, they reported
that HPV type 52 DNA was present in only one case,
whereas similar to our study, HPV type 11 was the most
predominant type [37]. We also identified HPV type 39,
which has never been shown before to be present in
esophageal cancer in our country and many other
countries but this type has been reported by Matsha et
al. [37]. In a report in Latin-American region, they found
HPV in 25 % of ESCCs and HPV-16 was the most
frequent observed genotype, followed by both HPV-18
and HPV-59 in one case [41].
The detection of HPV 16 in malignant cases is more
frequently compared to HPV 18 [25, 26, 34, 41] or other
types including HPV 33 and 31 [28] and ‘low-risk’
HPVs including HPV 11 [42]. In the study by Matsha
et al. [38], similar to our study, they showed that HPV
11 and 39 were detected more frequently than HPV 16,
suggesting a possible role of HPV types other than 16
and 18 in the pathogenesis of esophageal cancer.
Among the three areas of China study, HPV6, 16, 18, 26,
45, 56, 57, and 58 were identified in positive specimens by
sequencing, but HPV16 and 57 were the most common
types in all regions, followed by HPV26 and HPV18. From
the HPV types reported in human ESCC from Colombia and
Chile, HPV-16 has been the most commonly identified,
followed by other high-risk HPV types, including HPV-18,
HPV-31, and HPV-35 [24]. HPV DNA were detected in
26.7 % of Indian patients with ESCC whiles HPV-16 and
18 were detected in 18.8 % of cases [43].
The 13 types of HPV identified in our study that 11
types of them (HPVs-16, 18, 31, 33, 35, 39, 45, 52, 58
and 59) are high-risk HPV types (potentially cancer
causing; ref. 21 and 22), and HPV-6 and HPV-11 being
the most commonly detected low-risk HPV type. In our
study, many specimens had multiple HPV infections
(Table 3). Among HPV positive specimens, 20.4 % were
co-infected with more than one HPV type that was
comparable to 15.8 % cases from China [34]. This seems
different from most studies, although double or even
multiple HPV infections have been reported in ESCC
from some areas of China [29].
The HPV transmission route in ESCCs is also of
interest. HPV infection of the esophageal mucosa is
highly suspected to occur in a direct route. In a recent
case–control study [43], HPV oral infection was strongly
associated with a sub-group of oropharyngeal squamous
cell carcinomas, in which high-risk sexual behaviors
(i.e. oral, vaginal) were recorded, regardless of alcohol
and tobacco use. In spite of the association between oral
HPV infection and sexual behavior, a Finnish HPV
Family Study [44] has shown that persistent high-risk
HPV infection in a mother is a major risk factor for oral
and genital infections by this virus in her children; this
susceptibility appears to be modulated by the immune
system. Thus, it could be argued that previous high-risk
HPV oral infection might predispose asymptomatic car-
riers for further ESCC progress.
Conclusion
To our knowledge, this is the first survey evaluating the
prevalence of HPV infection in Mazandaran, and drawing
attention to the unusual high proportion of many genotypes
of HPV except HPV16 and 18. We found evidence of an
association between esophageal squamous cell carcinoma
and HPV in the population studied. However, the findings
here serve to raise the possibility that HPV plays a role in
the etiology of esophageal carcinoma.




No. Sample code HPV genotypes











12 146 11, 45
13 149 11, 31, 33,35, 56
14 152 39, 45
15 161 6, 39, 45
16 163 11, 45, 52
17 165 35, 52
18 171 31, 33, 52
19 172 6
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